no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
|
Goad, Dakota W. |
|
|
24 |
C |
p. 59-76 |
article |
2 |
Adenoviral delivery of an immunomodulatory protein to the tumor microenvironment controls tumor growth
|
O'Connell, Patrick |
|
|
24 |
C |
p. 180-193 |
article |
3 |
A host non-coding RNA, nc886, plays a pro-viral role by promoting virus trafficking to the nucleus
|
Saruuldalai, Enkhjin |
|
|
24 |
C |
p. 683-694 |
article |
4 |
A novel fusion protein scaffold 18/12/TxM activates the IL-12, IL-15, and IL-18 receptors to induce human memory-like natural killer cells
|
Cubitt, Celia C. |
|
|
24 |
C |
p. 585-596 |
article |
5 |
A novel immune-related gene signature predicting survival in sarcoma patients
|
Ren, Haoyu |
|
|
24 |
C |
p. 114-126 |
article |
6 |
A novel PD-L1-targeted shark VNAR single-domain-based CAR-T cell strategy for treating breast cancer and liver cancer
|
Li, Dan |
|
|
24 |
C |
p. 849-863 |
article |
7 |
A novel TanCAR targeting IL13Rα2 and EphA2 for enhanced glioblastoma therapy
|
Muhammad, Niaz |
|
|
24 |
C |
p. 729-741 |
article |
8 |
Anti-CAIX BBζ CAR4/8 T cells exhibit superior efficacy in a ccRCC mouse model
|
Wang, Yufei |
|
|
24 |
C |
p. 385-399 |
article |
9 |
Anticancer effects of a single intramuscular dose of a minicircle DNA vector expressing anti-CD3/CD20 in a xenograft mouse model
|
Pang, Xiaojuan |
|
|
24 |
C |
p. 788-798 |
article |
10 |
A PD1 targeted nano-delivery system based on epigenetic alterations of T cell responses in the treatment of gastric cancer
|
Hu, Nan |
|
|
24 |
C |
p. 148-159 |
article |
11 |
Boosting antitumor response with PSMA-targeted immunomodulatory VLPs, harboring costimulatory TNFSF ligands and GM-CSF cytokine
|
Palameta, Soledad |
|
|
24 |
C |
p. 650-662 |
article |
12 |
Carboranes as unique pharmacophores in antitumor medicinal chemistry
|
Chen, Yu |
|
|
24 |
C |
p. 400-416 |
article |
13 |
CD3 engagement as a new strategy for allogeneic “off-the-shelf” T cell therapy
|
Li, Gongbo |
|
|
24 |
C |
p. 887-896 |
article |
14 |
CD47-targeted optical molecular imaging and near-infrared photoimmunotherapy in the detection and treatment of bladder cancer
|
Yang, Yongjun |
|
|
24 |
C |
p. 319-330 |
article |
15 |
CIP4 targeted to recruit GTP-Cdc42 involving in invadopodia formation via NF-κB signaling pathway promotes invasion and metastasis of CRC
|
Hu, Zhiyan |
|
|
24 |
C |
p. 873-886 |
article |
16 |
CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma
|
Cai, Juan |
|
|
24 |
C |
p. 755-771 |
article |
17 |
Circular RNA circLAMA3 inhibits the proliferation of bladder cancer by directly binding an mRNA
|
Wu, Shuilian |
|
|
24 |
C |
p. 742-754 |
article |
18 |
DNA immunotherapy targeting BARF1 induces potent anti-tumor responses against Epstein-Barr-virus-associated carcinomas
|
Zhu, Xizhou |
|
|
24 |
C |
p. 218-229 |
article |
19 |
Dual-targeting vaccine of FGL1/CAIX exhibits potent anti-tumor activity by activating DC-mediated multi-functional CD8 T cell immunity
|
Chai, Dafei |
|
|
24 |
C |
p. 1-13 |
article |
20 |
Emerging function and clinical significance of extracellular vesicle noncoding RNAs in lung cancer
|
Shan, Chan |
|
|
24 |
C |
p. 814-833 |
article |
21 |
ENO1 and Cancer
|
Huang, Chen Kai |
|
|
24 |
C |
p. 288-298 |
article |
22 |
Exosomal circSHKBP1 participates in non-small cell lung cancer progression through PKM2-mediated glycolysis
|
Chen, Wenbiao |
|
|
24 |
C |
p. 470-485 |
article |
23 |
Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting desmocollin-2
|
Yang, Wenjuan |
|
|
24 |
C |
p. 612-623 |
article |
24 |
Expanding the role of interventional oncology for advancing precision immunotherapy of solid tumors
|
Kimura, Yasushi |
|
|
24 |
C |
p. 194-204 |
article |
25 |
Feasibility study of a novel preparation strategy for anti-CD7 CAR-T cells with a recombinant anti-CD7 blocking antibody
|
Ye, Jing |
|
|
24 |
C |
p. 719-728 |
article |
26 |
Fibroblast-derived LPP as a biomarker for treatment response and therapeutic target in gastric cancer
|
Wang, Hao |
|
|
24 |
C |
p. 547-560 |
article |
27 |
Gene knock-out chain reaction enables high disruption efficiency of HPV18 E6/E7 genes in cervical cancer cells
|
Tian, Rui |
|
|
24 |
C |
p. 171-179 |
article |
28 |
Highly efficient PD-1-targeted CRISPR-Cas9 for tumor-infiltrating lymphocyte-based adoptive T cell therapy
|
Chamberlain, Christopher Aled |
|
|
24 |
C |
p. 417-428 |
article |
29 |
Hsa_circ_0001666 promotes non-small cell lung cancer migration and invasion through miR-1184/miR-548I/AGO1 axis
|
Wang, Xueting |
|
|
24 |
C |
p. 597-611 |
article |
30 |
IL-13Rα2 humanized scFv-based CAR-T cells exhibit therapeutic activity against glioblastoma
|
Xu, Chang |
|
|
24 |
C |
p. 443-451 |
article |
31 |
Immune priming using DC- and T cell-targeting gene therapy sensitizes both treated and distant B16 tumors to checkpoint inhibition
|
Wenthe, Jessica |
|
|
24 |
C |
p. 429-442 |
article |
32 |
Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
|
Naumenko, Victor A. |
|
|
24 |
C |
p. 663-682 |
article |
33 |
Integrated analysis reveals the molecular features of fibrosis in triple-negative breast cancer
|
Ding, Jia-Han |
|
|
24 |
C |
p. 624-635 |
article |
34 |
Intracranial delivery of synthetic mRNA to suppress glioblastoma
|
Peng, Hao |
|
|
24 |
C |
p. 160-170 |
article |
35 |
Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer
|
Rangsitratkul, Coby |
|
|
24 |
C |
p. 507-521 |
article |
36 |
Isolation of TCR genes with tumor-killing activity from tumor-infiltrating and circulating lymphocytes in a tumor rejection cynomolgus macaque model
|
Terada, Koji |
|
|
24 |
C |
p. 77-86 |
article |
37 |
Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials
|
Wang, Shuhang |
|
|
24 |
C |
p. 799-813 |
article |
38 |
Lazertinib improves the efficacy of chemotherapeutic drugs in ABCB1 or ABCG2 overexpression cancer cells in vitro, in vivo, and ex vivo
|
Fan, Yingfang |
|
|
24 |
C |
p. 636-649 |
article |
39 |
LINC01296 promotes neuroblastoma tumorigenesis via the NCL-SOX11 regulatory complex
|
Wang, Jing |
|
|
24 |
C |
p. 834-848 |
article |
40 |
lncRNA SNHG26 promoted the growth, metastasis, and cisplatin resistance of tongue squamous cell carcinoma through PGK1/Akt/mTOR signal pathway
|
Jiang, Qingkun |
|
|
24 |
C |
p. 355-370 |
article |
41 |
NAD+ depletion enhances reovirus-induced oncolysis in multiple myeloma
|
Kennedy, Barry E. |
|
|
24 |
C |
p. 695-706 |
article |
42 |
Narciclasine targets STAT3 via distinct mechanisms in tamoxifen-resistant breast cancer cells
|
Lv, Chao |
|
|
24 |
C |
p. 340-354 |
article |
43 |
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges
|
Poggi, Alessandro |
|
|
24 |
C |
p. 26-42 |
article |
44 |
Non-coding RNAs and glioblastoma: Insight into their roles in metastasis
|
Mousavi, Seyed Mojtaba |
|
|
24 |
C |
p. 262-287 |
article |
45 |
Nucleic acids and proteins carried by exosomes of different origins as potential biomarkers for gynecologic cancers
|
Ye, Miaomiao |
|
|
24 |
C |
p. 101-113 |
article |
46 |
Oncolytic adenovirus-mediated expression of decorin facilitates CAIX-targeting CAR-T therapy against renal cell carcinoma
|
Zhang, Chen |
|
|
24 |
C |
p. 14-25 |
article |
47 |
Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
|
Veinalde, Rūta |
|
|
24 |
C |
p. 43-58 |
article |
48 |
Oncolytic vaccinia virus injected intravenously sensitizes pancreatic neuroendocrine tumors and metastases to immune checkpoint blockade
|
Inoue, Mitsuko |
|
|
24 |
C |
p. 299-318 |
article |
49 |
Oncolytic Zika virus promotes intratumoral T cell infiltration and improves immunotherapy efficacy in glioblastoma
|
Chen, Lishu |
|
|
24 |
C |
p. 522-534 |
article |
50 |
PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1
|
Zhang, Zhifang |
|
|
24 |
C |
p. 331-339 |
article |
51 |
Potential for reversing miR-634-mediated cytoprotective processes to improve efficacy of chemotherapy against oral squamous cell carcinoma
|
Tran, Phuong Xuan |
|
|
24 |
C |
p. 897-908 |
article |
52 |
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer
|
Kim, Sang-In |
|
|
24 |
C |
p. 864-872 |
article |
53 |
Promoting role of pentraxin-3 in esophageal squamous cell carcinoma
|
Fan, Zhirui |
|
|
24 |
C |
p. 772-787 |
article |
54 |
RETRACTED: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment
|
Xiong, Hanchu |
|
|
24 |
C |
p. 371-384 |
article |
55 |
SEC coupled with in-line multiple detectors for the characterization of an oncolytic Coxsackievirus
|
Deng, James Z. |
|
|
24 |
C |
p. 139-147 |
article |
56 |
SNX5 suppresses clear cell renal cell carcinoma progression by inducing CD44 internalization and epithelial-to-mesenchymal transition
|
Zhou, Qingqing |
|
|
24 |
C |
p. 87-100 |
article |
57 |
Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures
|
Stepanenko, Aleksei A. |
|
|
24 |
C |
p. 230-248 |
article |
58 |
Synthetic mRNA-based gene therapy for glioblastoma: TRAIL-mRNA synergistically enhances PTEN-mRNA-based therapy
|
Tang, Xiangjun |
|
|
24 |
C |
p. 707-718 |
article |
59 |
Thank you to our 2021 reviewers
|
|
|
|
24 |
C |
p. 467-469 |
article |
60 |
The miR-23a/27a/24-2 cluster promotes postoperative progression of early-stage non-small cell lung cancer
|
Fan, Xiaoqing |
|
|
24 |
C |
p. 205-217 |
article |
61 |
The next wave of cellular immunotherapies in pancreatic cancer
|
Yeo, Dannel |
|
|
24 |
C |
p. 561-576 |
article |
62 |
The NRF2-dependent transcriptional axis, XRCC5/hTERT drives tumor progression and 5-Fu insensitivity in hepatocellular carcinoma
|
Liu, Tianze |
|
|
24 |
C |
p. 249-261 |
article |
63 |
Therapeutic effects of mesenchymal stem cells loaded with oncolytic adenovirus carrying decorin on a breast cancer lung metastatic mouse model
|
Zhang, Yuning |
|
|
24 |
C |
p. 486-496 |
article |
64 |
Therapeutic effects of TM4SF5-targeting chimeric and humanized monoclonal antibodies in hepatocellular and colon cancer models
|
Ko, Dongjoon |
|
|
24 |
C |
p. 452-466 |
article |
65 |
The role of long non-coding RNAs in the pathogenesis of head and neck squamous cell carcinoma
|
Jiang, Man |
|
|
24 |
C |
p. 127-138 |
article |
66 |
TTN-AS1 accelerates the growth and migration of nasopharyngeal carcinoma cells via targeting miR-876-5p/NETO2
|
Chen, Xinping |
|
|
24 |
C |
p. 535-546 |
article |
67 |
UXT, a novel DNMT3b-binding protein, promotes breast cancer progression via negatively modulating lncRNA MEG3/p53 axis
|
Huang, Zhong-Feng |
|
|
24 |
C |
p. 497-506 |
article |
68 |
Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
|
Liang, Chris |
|
|
24 |
C |
p. 577-584 |
article |